NFATC3 and cardiac hypertrophy: Overall, these results demonstrate that Nfatc3 is a target of miR-145-5p, and that Jpx acts as the competing endogenous RNA (ceRNA) of Nfatc3 by absorbing miR-145-5p in testosterone-induced cardiac hypertrophy.